Clinical trial
The Effect of Quercetin in Sarcoidosis
NCT00402623 · Maastricht University Medical Center, Other · Completed
Key facts
| NCT number | NCT00402623 |
|---|---|
| Title | The Effect of Quercetin in Sarcoidosis |
| Official title | The Effect of Quercetin on the Increased Inflammatory and Decreased Antioxidant Status in Sarcoidosis |
| Lead sponsor | Maastricht University Medical Center, Other |
| Collaborators | ZonMw: The Netherlands Organisation for Health Research and Development |
| Status | Completed |
| Study type | Interventional |
| Conditions | Sarcoidosis |
| Intervention type | Dietary Supplement, Other |
| Interventions | quercetin, placebo |
| Enrollment | 18 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Nov 22, 2006 |
| Last update posted | Feb 24, 2017 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: